News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results